Mallath Mohandas K , Chawla Tanuj. Curing more colorectal cancer. National Medical Journal of India. 2016 May-Jun; 29(3): 155-157.
Loading...
Date
2016-05
Authors
Journal Title
Journal ISSN
Volume Title
Publisher
Abstract
Dalerba P, Sahoo D, Paik S, Guo X, Yothers G, Song N, WilcoxFogel
N, Forgó E, Rajendran PS, Miranda SP, Hisamori S,
Hutchison J, Kalisky T, Qian D, Wolmark N, Fisher GA, van de
Rijn M, Clarke MF. (Herbert Irving Comprehensive Cancer
Center and the Departments of Pathology and Cell Biology and
Medicine, Columbia University, New York, USA; Institute for
Stem Cell Biology and Regenerative Medicine and the Departments
of Pathology and Medicine, Division of Oncology, Stanford
University, Stanford, and the Departments of Pediatrics and
Computer Science and Engineering, University of California San
Diego, San Diego, California, USA; Faculty of Engineering, BarIlan
University, Ramat Gan, Israel; the National Surgical Adjuvant
Breast and Bowel Project, NRG Oncology and the Allegheny
Cancer Center at Allegheny General Hospital, Pittsburgh, USA;
Severance Biomedical Science Institute, Yonsei University College
of Medicine, Seoul, South Korea; Department of Biochemistry
and Molecular Biology, Medical School of Henan University,
Kaifeng, China.) CDX2 as a prognostic biomarker in stage II and
stage III colon cancer. N Engl J Med 2016;374:211–22.
Description
Keywords
Citation
Mallath Mohandas K, Chawla Tanuj. Curing more colorectal cancer. National Medical Journal of India. 2016 May-Jun; 29(3): 155-157.